622 Development of in vitro transcribed messenger ribonucleic acid therapeutics for cystic fibrosis
Autor: | Maeshima, R., Attwood, M., Walker, A., Tagalakis, A., Weissman, D., McAnulty, R., O'Callaghan, C., Baines, D., Hart, S. |
---|---|
Zdroj: | In Journal of Cystic Fibrosis October 2022 21 Supplement 2:S343-S343 |
Databáze: | ScienceDirect |
Externí odkaz: |